- Home
- EXEL vs EMN Comparison
EXEL vs EMN Comparison
Compare EXEL & EMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- EMN
- Stock Information
- Founded
- EXEL 1994
- EMN 1920
- Country
- EXEL United States
- EMN United States
- Employees
- EXEL N/A
- EMN N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- EMN Major Chemicals
- Sector
- EXEL Health Care
- EMN Industrials
- Exchange
- EXEL Nasdaq
- EMN Nasdaq
- Market Cap
- EXEL 9.8B
- EMN 9.2B
- IPO Year
- EXEL 2000
- EMN 1993
- Fundamental
- Price
- EXEL $43.04
- EMN $78.33
- Analyst Decision
- EXEL Buy
- EMN Buy
- Analyst Count
- EXEL 18
- EMN 13
- Target Price
- EXEL $38.76
- EMN $99.46
- AVG Volume (30 Days)
- EXEL 3.9M
- EMN 1.8M
- Earning Date
- EXEL 05-13-2025
- EMN 07-24-2025
- Dividend Yield
- EXEL N/A
- EMN 4.24%
- EPS Growth
- EXEL 237.58
- EMN 1.14
- EPS
- EXEL 2.20
- EMN 7.86
- Revenue
- EXEL $2,298,922,000.00
- EMN $9,362,000,000.00
- Revenue This Year
- EXEL $10.39
- EMN N/A
- Revenue Next Year
- EXEL $10.74
- EMN $3.35
- P/E Ratio
- EXEL $19.53
- EMN $9.98
- Revenue Growth
- EXEL 24.49
- EMN 2.79
- 52 Week Low
- EXEL $20.40
- EMN $70.90
- 52 Week High
- EXEL $48.85
- EMN $114.50
- Technical
- Relative Strength Index (RSI)
- EXEL 59.93
- EMN 43.74
- Support Level
- EXEL $42.21
- EMN $79.54
- Resistance Level
- EXEL $43.75
- EMN $82.83
- Average True Range (ATR)
- EXEL 1.60
- EMN 1.86
- MACD
- EXEL -0.09
- EMN 0.05
- Stochastic Oscillator
- EXEL 53.96
- EMN 10.14
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About EMN Eastman Chemical Company
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.